AURO-BROMFENAC

USDailyMed:Bromfenac S01BC11(WHO) CA:℞-onlyUS:℞-onlyEU:Rx-only 2-[2-amino-3-(4-bromobenzoyl)phenyl]acetic acid 91714-94-2Y 60726 7131 DB00963Y 54730Y 864P0921DW D07541Yas salt:D03163Y CHEBI:240107Y ChEMBL1077Y DTXSID7040655 Interactive image O=C(c1ccc(Br)cc1)c2cccc(c2N)CC(=O)O InChI=1S/C15H12BrNO3/c16-11-6-4-9(5-7-11)15(20)12-3-1-2-10(14(12)17)8-13(18)19/h1-7H,8,17H2,(H,18,19)YKey:ZBPLOVFIXSTCRZ-UHFFFAOYSA-NY Bromfenacis anonsteroidal anti-inflammatory drug(NSAID)marketed in the US as anophthalmicsolution (brand namesProlensaandBromday,prior formulation brand nameXibrom, which has since been discontinued) byISTA Pharmaceuticalsfor short-term, local use. Prolensa and Bromday are the once-daily formulation of bromfenac, while Xibrom was approved for twice-daily administration. In the European Union, the brand name isYellox. Bromfenac is indicated for the treatment of ocular inflammation and pain aftercataract surgery.